A population-based study of concurrent prescriptions of opioid analgesic and selective serotonin reuptake inhibitor medications during pregnancy and risk for adverse birth outcomes.
Ayesha C SujanMartin E RickertPatrick D QuinnChristina LudemaKelsey K WiggsHenrik LarssonPaul LichtensteinCatarina AlmqvistAnna Sara ÖbergBrian M D'OnofrioPublished in: Paediatric and perinatal epidemiology (2020)
Compared with unexposed pregnancies, those with either medication alone had a small increased risk for preterm birth but no increased risk for small for gestational age. The magnitude of associations with combined exposure to both medications were not greater than the sum of the associations with each medication considered individually.
Keyphrases
- gestational age
- preterm birth
- birth weight
- adverse drug
- low birth weight
- healthcare
- chronic pain
- pain management
- type diabetes
- emergency department
- body mass index
- squamous cell carcinoma
- locally advanced
- anti inflammatory
- metabolic syndrome
- physical activity
- pregnant women
- radiation therapy
- glycemic control
- weight gain